<?xml version="1.0" encoding="UTF-8"?>
<p id="p0170">Second, given current realities, it is likely that more than one Zika vaccine type may need to be developed. For example, an inactivated vaccine will be required for pregnant women and perhaps women of childbearing age. Live attenuated vaccines could be deployed in children, males, and older adults. Higher-potency or adjuvanted vaccines may be needed for the immunosenescent elderly and those who are immunocompromised. DNA- or vector-based vaccines may prove more immunogenic and result in longer-lasting immunity.</p>
